Evidence map›Paper›PMID 42515620›Full record

ArticleViruses2026

Fluorescent Powassan Reporter Viruses Infect Neuron, Astrocyte and Microglial Cell Lines Independent of Attenuating D308N Envelope Protein Modification.

Autumn Y Laird, Varvara Kirillov, Elena E Gorbunova, Alexander Vostrov, Genevieve Rochlin, Catherine E Finnerty, Aisling G Byrne, Priscila Ikeda, Romario Matos, Marissa R Lindner and 2 more

Abstract read
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Autumn Y LairdDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.ORCID 0009-0006-4389-7139
Varvara KirillovDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.
Elena E GorbunovaDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.
Alexander VostrovDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.
Genevieve RochlinDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.
Catherine E FinnertyDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.
Aisling G ByrneDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.
Priscila IkedaDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.
Romario MatosDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.
Marissa R LindnerDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.
Hwan Keun KimDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.ORCID 0000-0003-2095-9705
Erich R MackowDepartment of Microbiology and Immunology, Center for Infectious Disease, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-5222, USA.ORCID 0000-0001-9156-1222

Funding

Molecular basis of immunity to tick-borne rickettsiosesR01AI152208 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI KIM, HWAN KEUN · 2021 to 2025
$2.8M
Mechanisms of Age Dependent Powassan Virus Neurovirulence R01AI179817 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI Erich R Mackow · 2024 to 2026
$2.2M
CNS Senescence and Immunopathology in Lethal POWV Infection of Aged MiceR01AI183762 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI Erich R Mackow · 2024 to 2026
$2.2M
Transposon mutagenesis of Rickettsia for studying Rickettsia-host-vector interactionsR61AI179732 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI Hwan Keun Kim · 2024 to 2026
$837k
Innate Immune Regulation of Powassan Virus NeurovirulenceR21AI180288 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI MACKOW, ERICH R · 2024 to 2025
$435k
National Institute of Allergy and Infectious Diseases R01AI027044National Institute of Allergy and Infectious Diseases R01AI179817National Institute of Allergy and Infectious Diseases R21AI13173902National Institute of Allergy and Infectious Diseases R21AI180288National Institute of Allergy and Infectious Diseases RO1AI183762NIAID NIH HHS R01 AI152208NIAID NIH HHS R01 AI179817NIAID NIH HHS R01 AI183762NIAID NIH HHS R21 AI180288NIAID NIH HHS R61 AI179732United States Department of Defense W81XWH2210702
6 · The paper itself

Abstract

The Powassan virus (POWV) is a neurovirulent tick-borne virus that causes age-associated lethality and long-term neurologic sequelae in 50% of survivors. In aged mice the POWV strain LI9 mirrors human lethality and neuropathology; however, an avirulent POWV mutant, LI9-D308N, fails to enter the CNS or cause lethal disease. The D308N mutation is present in an envelope protein domain associated with cell attachment, yet the role of D308N mutations in cell tropism and neuroinvasion remains to be resolved. Here, we engineered fluorescent mScarlet3 and mNeonGreen reporter genes into WT LI9, and avirulent LI9-D308N viruses and assessed their ability to infect CNS cells in vitro. In addition, we generated replication-defective reporter POWVs that only replicate in NS1-expressing cells by replacing NS1 with fluorescent genes. Similar to WT LI9, fluorescent reporter POWVs spread focally and nonlytically, are stable following passage and reach high titers 2-5 dpi. In NS1-expressing VeroE6 cells, LI9-ΔNS1-FL reporters exhibited robust fluorescence 24 h post-infection (hpi), while fluorescence from LI9-reporter infections was first observed ~32 hpi. Comparing LI9-mScarlet3 and avirulent LI9-D308N-mScarlet3 viruses revealed no difference in their ability to infect human brain microvascular endothelial cells, pericytes, astrocytes, microglia or neuronal cells in vitro. Notably, LI9-mScarlet3 viruses productively and persistently infected differentiated, neuron-like, SH-SY5Y cells without apparent cytotoxicity. These findings indicate that LI9-D308N is capable of infecting blood-brain-barrier and CNS cells, and suggest that neuroinvasion is restricted prior to LI9-D308N engaging CNS cells. These results are consistent with clearance of LI9-D308N from the blood, or the D308N mutation interfering with potential routes of POWV neuroinvasion. Collectively, fluorescent POWV reporter viruses provide insight into the mechanism of POWV neuroinvasion, permit analysis of replication-defective POWVs as vaccines and provide a means of analyzing POWV cell tropism, antivirals and cell-to-cell spread in BSL2 and BSL3 settings.

Indexed as

AstrocytesEncephalitis Viruses, Tick-BorneMicrogliaNeuronsViral Envelope ProteinsAnimalsCell LineGenes, ReporterHumansMiceViral TropismVirus ReplicationViral Envelope Proteinsattenuated mutantBSL2 POWVEnvelope EDIII mutantfluorescent reporter virusglial cellsneuronsNS1 deletionPowassan virus

Identifiers

PMID42515620
PMCPMC13431600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.